References
Souhami L, Seiferheld W, Brachman D et al (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93 – 05 protocol. Int J Radiat Oncol Biol Phys 60:853–860
Fernandez-Gil B, Irene (2022) OP60 Preoperative Radiation in Glioblastoma undirectly regulates p53 expression improving survival in a preclinical model.
Mayo Clinic (2022) Preoperative Radiosurgery in High Grade Glioma: a phase I/IIA clinical trial: the NeoGlioma Study. clinicaltrials.gov
Funding
This publication was made possible through the support of the Eveleigh Family Career Development Award for Cancer Research at Mayo Clinic in Florida.
Author information
Authors and Affiliations
Contributions
DMT wrote the main manuscript text and prepared figures, all authors reviewed and edited the manuscript and approved submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Conflict of interest
Dr. Trifiletti reports clinical trial research support from the Florida Department of Health, Varian Medical Systems, and Blue Earth Diagnostics Ltd., publishing fees from Springer Inc., as well as consulting fees from Boston Scientific Corporation. Dr. Burri receives funds from Novocure for service on a DSMC.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Trifiletti, D.M., Akinyelu, T., Burri, S.H. et al. Glioma inadvertently treated with preoperative stereotactic radiosurgery: focusing on safety. J Neurooncol 162, 247–249 (2023). https://doi.org/10.1007/s11060-023-04278-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-023-04278-7